Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Available vaccines offer protection against cervical, anal, oral, liver and stomach cancers.
New research shows that treating these viruses can reduce liver cancer risk.
A triple regimen of Opdivo, Yervoy and Cabometyx showed good antitumor activity, but severe side effects were common.
A compound found in veggies such as broccoli, kale and Brussels sprouts may help prevent a liver condition that increases cancer risk.
Transplants due to hepatitis C have dropped dramatically, especially among people with liver cancer.
Those with NAFLD or NASH and cirrhosis should undergo regular screening.
TRK inhibitor larotrectinib led to durable responses in people with colon, pancreatic, appendix, bile duct and liver cancers.
Tecentriq plus Avastin improved both overall survival and patient-reported outcomes.
Gastrointestinal cancers conference emphasizes patient quality of life.
Americans are drinking more, which puts them at risk of alcohol-related liver disease, heart disease, cancer and accidents.
The LIVER Act would increase funding for liver cancer and hepatitis B research and prevention.
This finding from a large study surprised and concerned researchers.
Cancer mortality fell by 29% between 1991 and 2017, largely driven by a decline in lung cancer deaths.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.